IoT-D is a Belgian product development company that is based on ICT solutions and IoT devices. Initially, it was created to provide an innovative structure and team for the development of great ideas. Later, the company started developing solutions targeted at various sectors including logistics, medical, gaming, music, and much more. Now, this company has raised funding targeted towards the growth of its first spin-out – Dermatoo.
€1M funding for Dermatoo’s growth
IoT-D announced that it raised €1M funding following its first round since its debut in 2018. This investment will be used to accelerate the growth of Dermatoo, which is its first spin-out that is active in the remote medicine industry since 2018.
IoT-D is a startup studio founded in 2018 which offers technological solutions in order to create high potential businesses. Horizontally structured, the company claims to gather complementary and multidisciplinary teams constituted by young and gifted graduates, along with senior entrepreneurs.
The company thanks NOSHAQ, the support from Walloon Region for innovation, and private investors. The first round of investment will help Dermatoo reinforce the team and make its first devices useful. Noshaq is a Belgian investment fund and project developer with a portfolio of 464 companies and €600M of resources.
Julien Delarbre, IoT-D’s CEO explains, “We believe that the medicine of the future should make the life of healthcare professionals easier, by offering them smart solutions for a better management of care services. Beyond optimising the administrative costs of care, our technology helps enhance the relationship between patient and professionals by suppressing time-consuming tasks and putting patients at the centre of medical attention.”
What does Dermatoo do?
Dermatoo provides medical solutions that are designed to facilitate the monitoring of patients and healthcare professionals’ interventions. This is possible with advanced sharing of medical observations. Initiated by IoT-D, this project is backed by experts and investors from the healthcare industry and has generated interest among foreign firms.
Stock photo from metamorworks/Shutterstock
